Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns?
Mark N Belkin1, Gaurav A Upadhyay2
1Center for Arrhythmia Care, Section of Cardiology, The University of Chicago Medicine, 5841 S. Maryland Avenue, MC 9024, Chicago, IL, 60637, USA.
Cardiac Resynchronization Therapy (CRT) utility in non-Left Bundle Branch Block (LBBB) patients is debated. Specific patient subgroups and advanced lead placement techniques show promise for improved CRT response.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac Resynchronization Therapy (CRT) is established for heart failure (HF) patients with Left Bundle Branch Block (LBBB).
- CRT use in non-LBBB patients, especially those with Right Bundle Branch Block (RBBB), is controversial due to high non-response rates.
Purpose of the Study:
- To assess the clinical utility and effectiveness of CRT in patients who do not have LBBB.
- To identify specific patient profiles within the non-LBBB population that may benefit from CRT.
Main Methods:
- Review of recent studies investigating CRT response in non-LBBB patient cohorts.
- Analysis of advanced imaging and mapping techniques for optimizing LV lead placement.
- Identification of patient characteristics associated with CRT non-response and response.
Main Results:
- Sub-populations of non-LBBB patients, including those with prolonged PR intervals (≥230 ms) or RBBB with left-sided delay, show potential CRT benefits.
- Significant right ventricular pacing burden is another factor influencing CRT response in non-LBBB patients.
- Advanced LV lead placement guided by electrical and mechanical mapping improves CRT outcomes by targeting dyssynchrony.
Conclusions:
- CRT may be beneficial for select non-LBBB patients, particularly when guided by advanced imaging and patient selection criteria.
- Optimized LV lead placement targeting electrical and mechanical dyssynchrony is crucial for maximizing CRT efficacy in non-LBBB populations.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy


